Denisa Muraru1, Luigi P Badano2,3, Yasufumi Nagata4, Elena Surkova1,5, Yosuke Nabeshima4, Davide Genovese1, Yutaka Otsuji4, Valentina Guida2, Danila Azzolina1, Chiara Palermo1, Masaaki Takeuchi6. 1. Department of Cardiac, Thoracic and Vascular Sciences, University of Padua School of Medicine, Via Giustiniani 2, Padua, Italy. 2. Istituto Auxologico Italiano, IRCCS, Cardiology Unit and Department of Cardiovascular, Neural and Metabolic Sciences, San Luca Hospital, Piazzale Brescia, 20, Milan, Italy. 3. Department of Medicine and Surgery, University of Milano-Bicocca, Piazza dell'Ateneo Nuovo 1, Milan, Italy. 4. Second Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Iseigaoka 1-1, Yahatanishiku, Kitakyushu, Japan. 5. Cardiac Division, Department of Echocardiography, Royal Brompton Hospital, Royal Brompton and Harefield NHS Foundation Trust, Sydney Street, Chelsea, London, UK. 6. Department of Laboratory and Transfusion Medicine, School of Medicine, University of Occupational and Environmental Health, Iseigaoka 1-1, Yahatanishiku, Kitakyushu, Japan.
Abstract
AIMS: Transthoracic 3D echocardiography (3DE) has been shown to be feasible and accurate to measure right ventricular (RV) ejection fraction (EF) when compared with cardiac magnetic resonance (CMR). However, RV EF, either measured with CMR or 3DE, has always been reported as normal (RV EF > 45%) or abnormal (RV EF ≤ 45%). We therefore sought to identify the partition values of RV EF to stratify RV dysfunction in mildly, moderately, or severely reduced as we are used to do with the left ventricle. METHODS AND RESULTS: We used 3DE to measure RV EF in 412 consecutive patients (55 ± 18 years, 65% men) with various cardiac conditions who were followed for 3.7 ± 1.4 years to obtain the partition values which defined mild, moderate, and severe reduction of RV EF (derivation cohort). Then, the prognostic value of these partition values was tested in an independent population of 446 patients (67 ± 14 years, 58% men) (validation cohort). During follow-up, we recorded 59 cardiac deaths (14%) in the derivation cohort. Using K-Adaptive partitioning for survival data algorithm we identified four groups of patients with significantly different mortality according to RV EF: very low > 46%, 40.9% < low ≤ 46%, 32.1% < moderate ≤ 40.9%, and high ≤ 32.1%. To make the partition values easier to remember, we approximated them to 45%, 40%, and 30%. During 4.1 ± 1.2 year follow-up, 38 cardiac deaths and 88 major adverse cardiac events (MACE) (cardiac death, non-fatal myocardial infarction, ventricular fibrillation, or admission for heart failure) occurred in the validation cohort. The partition values of RV EF identified in the derivation cohort were able to stratify both the risk of cardiac death (log-rank = 100.1; P < 0.0001) and MACEs (log-rank = 117.6; P < 0.0001) in the validation cohort too. CONCLUSION: Our study confirms the independent prognostic value of RV EF in patients with heart diseases, and identifies the partition values of RV EF to stratify the risk of cardiac death and MACE. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: Transthoracic 3D echocardiography (3DE) has been shown to be feasible and accurate to measure right ventricular (RV) ejection fraction (EF) when compared with cardiac magnetic resonance (CMR). However, RV EF, either measured with CMR or 3DE, has always been reported as normal (RV EF > 45%) or abnormal (RV EF ≤ 45%). We therefore sought to identify the partition values of RV EF to stratify RV dysfunction in mildly, moderately, or severely reduced as we are used to do with the left ventricle. METHODS AND RESULTS: We used 3DE to measure RV EF in 412 consecutive patients (55 ± 18 years, 65% men) with various cardiac conditions who were followed for 3.7 ± 1.4 years to obtain the partition values which defined mild, moderate, and severe reduction of RV EF (derivation cohort). Then, the prognostic value of these partition values was tested in an independent population of 446 patients (67 ± 14 years, 58% men) (validation cohort). During follow-up, we recorded 59 cardiac deaths (14%) in the derivation cohort. Using K-Adaptive partitioning for survival data algorithm we identified four groups of patients with significantly different mortality according to RV EF: very low > 46%, 40.9% < low ≤ 46%, 32.1% < moderate ≤ 40.9%, and high ≤ 32.1%. To make the partition values easier to remember, we approximated them to 45%, 40%, and 30%. During 4.1 ± 1.2 year follow-up, 38 cardiac deaths and 88 major adverse cardiac events (MACE) (cardiac death, non-fatal myocardial infarction, ventricular fibrillation, or admission for heart failure) occurred in the validation cohort. The partition values of RV EF identified in the derivation cohort were able to stratify both the risk of cardiac death (log-rank = 100.1; P < 0.0001) and MACEs (log-rank = 117.6; P < 0.0001) in the validation cohort too. CONCLUSION: Our study confirms the independent prognostic value of RV EF in patients with heart diseases, and identifies the partition values of RV EF to stratify the risk of cardiac death and MACE. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: A Malagoli; A Albini; G E Mandoli; A Baggiano; G Vinco; F Bandera; A D'Andrea; R Esposito; F D'Ascenzi; R Sorrentino; C Santoro; G Benfari; F Contorni; M Cameli Journal: Int J Cardiovasc Imaging Date: 2021-06-10 Impact factor: 2.357
Authors: A Hagendorff; A Helfen; R Brandt; E Altiok; O Breithardt; D Haghi; J Knierim; D Lavall; N Merke; C Sinning; S Stöbe; C Tschöpe; F Knebel; S Ewen Journal: Clin Res Cardiol Date: 2022-06-04 Impact factor: 5.460
Authors: Mathias Orban; Stéphanie Bieber; Angelina Kraechan; Johannes C Hellmuth; Maximilian Muenchhoff; Clemens Scherer; Ines Schroeder; Michael Irlbeck; Stefan Kaeaeb; Steffen Massberg; Joerg Hausleiter; Ulrich Grabmaier; Ludwig T Weckbach Journal: Infection Date: 2021-01-30 Impact factor: 3.553
Authors: Tetsuji Kitano; Attila Kovács; Yosuke Nabeshima; Márton Tokodi; Alexandra Fábián; Bálint Károly Lakatos; Masaaki Takeuchi Journal: Front Cardiovasc Med Date: 2022-02-25
Authors: Elena Surkova; Attila Kovács; Márton Tokodi; Bálint Károly Lakatos; Béla Merkely; Denisa Muraru; Alessandro Ruocco; Gianfranco Parati; Luigi P Badano Journal: Circ Cardiovasc Imaging Date: 2021-09-30 Impact factor: 7.792